StockTipsArenaBeta

BUY Marksans Pharma Limited — Prakash Gaba

BUYMarksans Pharma Limited
Marksans Pharma share price target & all analyst calls

byPrakash GabaHorizon: NA (inferred Swing (≤2wk))9 Jun 2026via CNBC Awaaz.

Entry₹250Stated
Target₹265
Total upside +6.00% (call closed)
Stop loss₹240-4.00% risk
Exit₹26518 Jun 2026, 9:45 am
Target hit+6.00%0.00%upside left
Follow Prakash Gaba for new calls(30% target hit, 294 closed calls)Get alertsWatch MARKSANS for new buy/sell callsGet alertsSee 105 active Swing picks this week

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

AI Assessment

Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.

As of 22 Oct, 6:45 am IST
3 supporting0 opposing
Supports the BUY call (3)

2 advisors have active short-term BUY calls on this stock, all issued in the last 14 days

Advisor consensus · adjacent horizon·11 Jun · 6d ago

India Ratings and Research revised the outlook for Marksans Pharma Ltd's bank loan facilities to Positive from Stable.

BSE · Company Update·9 Jun · 1w ago

(opens in new tab)

Marksans Pharma Limited is acquiring 100% of Netherlands-based QliniQ B.V., expanding its presence in European markets.

NSE · Press Release·1 Jun · 2w ago

(opens in new tab)
Neutral / worth noting (0)

Nothing found in this tip’s window yet.

Weighs against the BUY call (0)

Nothing found in this tip’s window yet.

Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.

Other calls on Marksans Pharma

All analyst calls on Marksans Pharma

More from Prakash Gaba

Every call and its outcome